Rie Yokota

Dr. Rie Yokota

Department of Health Communication, The University of Tokyo, Tokyo, Japan
+1
orcid
Department of Health communication, School of Public Health,...

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Rie YokotaRie Yokota
Rie Yokota
TOTsuyoshi Okuhara
Tsuyoshi Okuhara
HOHiroko Okada
Hiroko Okada
EGEiko Goto
Eiko Goto
KSKeiko Sakakibara
Keiko Sakakibara
TKTakahiro Kiuchi
Takahiro Kiuchi
Japan has the highest number of cases of infertility treatment in the world. Studies have indicated that women undergoing infertility treatment feel stigmatized and suffer from psychological symptoms such as anxiety and depression. However, in Japan, few studies have quantitatively examined the association between the stigma of infertility and psychological symptoms, and, to our knowledge, no study has examined its association using a scale with tested reliability and validity. This study aims to quantitatively examine the relationship between infertility stigma and anxiety, depression, and psychological distress among women undergoing infertility treatment, using a scale that has been validated for reliability and validity. The cross-sectional study was conducted in December 2021 through a web-based survey of 254 participants undergoing infertility treatment. A multiple regression analysis was performed to examine the relationship between stigma and anxiety, depression, and psychological distress. Stigma was a statistically significant predictor of anxiety, depression, and psychological distress (standardized β = 0.58, p < 0.001; β = 0.50, p < 0.001; β = 0.62, p < 0.001, respectively) after controlling for sociodemographic and infertility characteristics. Future studies should examine the causal relationship between stigma and anxiety, depression, and psychological distress and how to intervene to reduce stigma among women undergoing infertility treatment.

EFEmi Furukawa
Emi Furukawa
TOTsuyoshi Okuhara
Tsuyoshi Okuhara
HOHiroko Okada
Hiroko Okada
Ritsuko ShirabeRitsuko Shirabe
Ritsuko Shirabe
Rie YokotaRie Yokota
Rie Yokota
TKTakahiro Kiuchi
Takahiro Kiuchi
Background: The Patient Education Materials Assessment Tool (PEMAT) systematically evaluates the understandability and actionability of patient education materials. This study aimed to develop a Japanese version of PEMAT and verify its reliability and validity. Methods: After assessing content validation, experts scored healthcare-related leaflets and videos according to PEMAT to verify inter-rater reliability. In validation testing with laypeople, the high-scoring material group (n = 800) was presented with materials that received high ratings on PEMAT, and the low-scoring material group (n = 799) with materials that received low ratings. Both groups responded to the understandability and actionability of the materials and perceived self-efficacy for the recommended actions. Results: The Japanese version of PEMAT showed strong inter-rater reliability (PEMAT-P: % agreement = 87.3, Gwet’s AC1 = 0.83. PEMAT-A/V: % agreement = 85.7, Gwet’s AC1 = 0.80). The high-scoring material group had significantly higher scores for understandability and actionability than the low-scoring material group (PEMAT-P: understandability 6.53 vs. 5.96, p < 0.001; actionability 6.04 vs. 5.49, p < 0.001; PEMAT-A/V: understandability 7.65 vs. 6.76, p < 0.001; actionability 7.40 vs. 6.36, p < 0.001). Perceived self-efficacy increased more in the high-scoring material group than in the low-scoring material group. Conclusions: Our study showed that materials rated highly on Japanese version of PEMAT were also easy for laypeople to understand and action.

29 September 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Rie YokotaRie Yokota
Rie Yokota
TOTsuyoshi Okuhara
Tsuyoshi Okuhara
HOHiroko Okada
Hiroko Okada
EGEiko Goto
Eiko Goto
KSKeiko Sakakibara
Keiko Sakakibara
TKTakahiro Kiuchi
Takahiro Kiuchi
The number of infertility treatment cycles in Japan is the highest worldwide. Studies have shown that stigma is a predictor of stress-related symptoms including anxiety and depression in women undergoing infertility treatment. Stress management to prevent stress-related symptoms may be crucial; however, few studies have examined the model of stigma and stress responses. Based on the stress-coping model, we hypothesized that stigma threatens the identity of such women and that coping failure increases stress responses. We aimed to explore the role of cognitive appraisals and coping strategies as mediators of the association between the stigma of infertility and stress responses. In December 2021, we conducted a cross-sectional study in Japan, in which 254 women undergoing infertility treatment completed a web-based survey. Hierarchical multiple regression analysis was conducted to analyze the associations between stigma, cognitive appraisals, coping strategies, and stress responses. The results showed that explanatory power increased with each additional variable in the following order: stigma, cognitive appraisals, and coping. Participants with a high level of stigma evaluated it as threatening, and used self-blame and venting coping strategies, and showed higher stress responses. Conversely, participants who used positive reframing coping strategies exhibited lower stress responses. Based on this, effective strategies to address stigma and stress responses are necessitated.

17 June 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
RIReina Iye
Reina Iye
TOTsuyoshi Okuhara
Tsuyoshi Okuhara
HOHiroko Okada
Hiroko Okada
Rie YokotaRie Yokota
Rie Yokota
TKTakahiro Kiuchi
Takahiro Kiuchi
Dietary supplements are widely advertised and the market is expanding worldwide. Research suggests that dietary supplement advertising may lead consumers to make inappropriate health-related decisions, to express behaviors such as overdosing, and to neglect healthy lifestyle behaviors. We conducted a content analysis of video advertisements for dietary supplements and described the content of advertisements with high numbers and frequent views. We analyzed 82 video advertisements on YouTube that promoted fat-reduction effects. We extracted 22 themes and classified them into 10 categories. The categories with the highest numbers of advertisements were “Exemption” (i.e., consuming the product frees the audience from refraining from binge eating) (20 ads, 24.4%) and “Health Concerns” (i.e., the product intake solves the health concerns of the audience) (19 ads, 23.2%). These advertisements may stimulate negative audience attitudes toward appropriate health behaviors. The category with the most frequent views was “Lifestyle” (i.e., adding product intake to a healthy lifestyle) (3,035,298 views). “Lifestyle” advertisements portray physical activity in a positive light and may promote appropriate health behaviors in the audience. We discuss the possible effects of the advertisements on audiences and consider issues for future research and practice.

23 November 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
TOTsuyoshi Okuhara
Tsuyoshi Okuhara
Rie YokotaRie Yokota
Rie Yokota
Ritsuko ShirabeRitsuko Shirabe
Ritsuko Shirabe
RIReina Iye
Reina Iye
HOHiroko Okada
Hiroko Okada
RARie Akamatsu
Rie Akamatsu
Objectives Public health institutions have alerted consumers about advertising for dietary supplements with false claims of preventing or treating COVID-19. We quantitatively and qualitatively examined newspaper advertisements for dietary supplements before and after the COVID-19 spread. Design Content analysis. Participants We analysed advertisements for dietary supplements in two major Japanese newspapers in February–July 2019 and February–July 2020. Our analysis covered 2167 advertisements. Results The number of advertisements for dietary supplements that claimed to be effective in infection prevention (p=0.009) and improving joint (p=0.002) and digestive functions (p=0.002) significantly increased after the spread of COVID-19 compared with before. Dietary supplements that claimed to be effective in preventing infection were advertised in combination with recommendations for gargling and handwashing. Such terms as ‘defence’ and ‘prevent’ were used to promote the preventive effect. Conclusions False and misleading claims in advertising for dietary supplements may result in consumer harm, such as overdosing and failure to take preventive behaviour. While the pandemic continues, there will be an increasing need for disseminating accessible information about the appropriate use of dietary supplements, consumer education and warnings to manufacturers.

9 March 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Rie YokotaRie Yokota
Rie Yokota
HOHiroko Okada
Hiroko Okada
TOTsuyoshi Okuhara
Tsuyoshi Okuhara
EGEiko Goto
Eiko Goto
EFEmi Furukawa
Emi Furukawa
TKTakahiro Kiuchi
Takahiro Kiuchi
The stigma of infertility negatively affects health, resulting in mental distress and poor quality of life. An appropriate scale is essential to examine the stigma experienced by infertile women and provide adequate interventions. Therefore, we developed a Japanese version of the Infertility Stigma Scale (ISS). After examining the content validity of this scale, we conducted an online survey of women undergoing fertility treatment to test the scale’s structural validity, internal consistency, intra-rater reliability, known-groups validity, convergent validity, and discriminant validity. A total of 254 participants were included in the analysis. The results of confirmatory factor analysis of four factors based on the original scale revealed the optimal fit. Cronbach’s alpha was 0.95 for the total score. Concerning test–retest analysis, the total score of the ISS and subscale had a high Spearman correlation coefficient (ρ = 0.61–0.88, p < 0.001). For convergent validity, the association between the ISS and social support, self-esteem, and family functioning was significantly negatively correlated. The results of the multitrait scaling analysis scale showed that correlations of all items exceeded 0.40, and scaling errors (7/81, 8.6%) were few. The Japanese version of the ISS was confirmed to have acceptable reliability and validity.